<DOC>
	<DOCNO>NCT02219750</DOCNO>
	<brief_summary>Comparison efficacy safety different insulin regimen basal bolus premixed insulin poorly control type 2 diabetes</brief_summary>
	<brief_title>Comparison Premixed Insulin With Basal-plus Insulin Type 2 Diabetes Patients</brief_title>
	<detailed_description>This 24-week , prospective , open-label , randomize , parallel-group study conduct approximately 140 patient type 2 diabetes Mackay Memorial Hospitals Mackay Memorial Hospital Taitung branch . After enrollment , eligible patient randomize 1:1 ratio either Basal-plus therapy ( BPT ) Preprandial premix therapy ( PPT ) . The effectiveness advance insulin therapy assess baseline 12 24 week initiation study prescription . The safety follow 24-week study period . All study procedure conduct obtain informed consent .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin aspart , insulin aspart protamine drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Short-Acting</mesh_term>
	<criteria>Men woman type 2 diabetes . ( World Health Organization classification ) &gt; 20 year age . Patients receive stable dos OADs least 12 week prior screen visit . treatment basal insulin plus OADs &gt; 3 month suboptimal glycemic control ( HbA1c &gt; 7 % ) FBG &lt; 130 mg/dl FBG â‰¥130 mg/dl , daily insulin dose &gt; 0.7U/kg history nocturnal hypoglycemia Patients willing able cooperate study give sign informed consent . Patients type 1 diabetes . History severe hypoglycemia hypoglycemia unawareness within prior 6 month . Patients receive investigational insulin 3 month receive investigational insulin treatment within 4 week prior screen visit . Patients hypersensitive insulin analog excipients . Patients currently pregnant/lactating , prepare pregnancy lactation . Renal dialysis patient , patient severe liver disease congestive heart failure BMI &gt; 40kg/m2 Excessive insulin resistance ( total daily insulin dose &gt; 2.0unit/kg )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>premix insuiln , basal-plus insulin</keyword>
</DOC>